Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce CRO Awards
Clinical Data
Biotech
Cassava stops Alzheimer's program as simufilam fails again
Months after seeing one phase 3 trial fail, the biotech plans to stop development altogether after chalking up another late-stage flop.
Nick Paul Taylor
Mar 25, 2025 9:12am
Unity's stock tumbles after eye treatment fails to match Eylea
Mar 24, 2025 11:11am
Surrozen drops sole clinical-stage drug over weak hepatitis data
Mar 24, 2025 10:50am
Opthea's eye disease drug defeated by Eylea in phase 3
Mar 24, 2025 5:24am
Elevation drops sole clinical-stage ADC, lays off 70% of staff
Mar 20, 2025 10:20am
Monte Rosa's broad molecular glue degrader plan comes unstuck
Mar 20, 2025 10:07am